Enhancement of Anti-Allergic effects mediated by the kampo medicine shoseiryuto (Xiao-Qing-Long-Tang in Chinese) with lysed enterococcus faecalis FK-23 in mice

Asian Pacific Journal of Allergy and Immunology

Volumn 28, Issue 1, 2010, Pages 59-66

  Shimada, Takashi ^a,b   Kondoh, Masatoshi ^a   Motonaga, Chie ^a   Kitamura, Yoshihisa ^a   Cheng, Lei ^b,c   Shi, HaiBo ^d   Enomoto, Tadao ^e   Tsuruta, Daisuke ^f   Ishii, Masamitsu ^f   Kobayashi, Hiromi ^f  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^e TOTTORI UNIVERSITY   (Japan)

^f OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KAMPO; LYSED ENTEROCOCCUS FAECALIS; POLLEN ANTIGEN; PROBIOTIC AGENT; PROTEIN DERIVATIVE; SHO SEIRYU TO; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG SENSITIZATION; ENTEROCOCCUS FAECALIS; EOSINOPHIL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; TREATMENT DURATION;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTIGENS, PLANT; ASTHMA; CEDRUS; CELLS, CULTURED; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; ENTEROCOCCUS FAECALIS; EOSINOPHILS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MEDICINE, KAMPO; MICE; MICE, INBRED BALB C; PERITONEAL CAVITY; STREPTOCOCCAL VACCINES;

EID: 77954546512     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Terasawa K. Evidence-based reconstruction of Kampo Medicines: Part I -Is Kampo CAM? Evid Based Complement Alternat Med 2004; 1: 11-6.
2. Kobayashi H, Mizuno N, Teramae H, et al. Diet and Japanese herbal medicine for recalcitrant atopic dermatitis: efficacy and safety. Drugs Exp Clin Res 2004; 30: 197-202.
3. Ishii M, Kobayashi H, Mizuno N, et al. Kampo therapy for adult atopic dermatitis by dieting and herbal medication: evaluating the disappearance of disease phases. Dieting and herbs for atopic dermatitis. Adv Exp Med Biol 2004; 546: 297-310.
4. Kobayashi H, Takahashi K, Mizuno N, Kutsuna H, Ishii M. An alternative approach to atopic dermatitis: part I-case-series presentation. Evid Based Complement Alternat Med 2004; 1: 49-62.
5. Kobayashi H, Takahashi K, Mizuno N, Kutsuna H, Ishii M. An alternative approach to atopic dermatitis: part II-case-series presentation. Evid Based Complement Alternat Med 2004; 1: 145-55.
6. Kobayashi H, Ishii M, Takeuchi S, et al. Efficacy and safety of a traditional herbal medicine, Hochu-ekki-to in the longterm management of Kikyo (delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Alternat Med 2008; Jan 31. [Epub ahead of print]
7. Kumagai A. Kampo and the treatment of allergy. In: Hosoya E, Yamamura Y. eds. Recent advances in the pharmacology of Kampo (Japanese herbal) medicines. Amsterdam: Excerpta Medica 1998; p. 237.
8. Takeuchi Y, Nishimura Y, Yoshikawa T, Kuriyama J, Kimura Y, Saiga T. A comparison between Chinese blended medicine "shoseiryuto", tranilast and ketotifen on the antiallergic action in guinea pigs. Arerugi 1985; 34: 387-93 (in Japanese).
9. Yamahara J, Yamada T, Kimura H, Sawada T, Fujimura H. Biochemically active principles of crude drugs. Antiallergic principles of "Shoseiryu-to". I: effect on delayed-type allergy reaction. Yakugaku Zasshi 1982; 102: 881-6 (In Japanese).
10. Tanno Y, Shindoh Y, Takishima T. Modulation of human basophil growth in vitro by xiao-qing-long-tang (syo-seiryu-to), chai-pu-tang (saiboku-to), qing-fei-tang (seihai-to), baicalein and ketotifen. Am J Chin Med 1994; 22: 191-6.
11. Tanaka A, Ohashi Y, Kakinoki Y, Washio Y, Yamada K, Nakai Y. The herbal medicine Shoseiryu-to inhibits allergen-induced synthesis of tumor necrosis factor a by peripheral blood mononuclear cells in patients with perennial allergic rhinitis. Acta Otolaryngol 1998; 538: 118-25.
12. Sakaguchi M, Iizuka A, Yuzurihara M, Ishige A, Komatsu Y, Matsumiya T. Pharmacological characteristics of Shoseiryu-to, an anti-allergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in brain. Method Find Exp Clin Pharmacol 1996; 18: 41-7.
13. Ikeda Y, Kaneko A, Yamamoto M, Ishige A, Sasaki H. Possible involvement of suppression of Th2 differentiation in the anti-allergic effect of Shoseiryu-to in mice. Jpn J Pharmacol 2002; 90: 328-36.
14. Kao ST, Wang SD, Wang JY, Yu CK, Lei HY. The effect of Chinese herbal medicine, xiao-qing-long-tang (XQLT), on allergen-induced bronchial inflammation in mite-sensitized mice. Allergy 2000; 55: 1127-33.
15. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001; 361: 1869-71.
16. Rosenfeldt V, Benfeldt E, Neilsen SD, et al. Effect of probiotic Lactobacillus strain in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-95.
17. Wang MF, Lin HC, Wang YY, Hsu CH. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004; 15: 152-8.
18. Shimada T, Cheng L, Ide M, Fukuda S, Enomoto T, Shirakawa T. Effect of lysed Enterococcus faecalis FK-23 (LFK) on allergen-induced peritoneal accumulation of eosinophils in mice. Clin Exp Allergy 2003; 3: 684-7.
19. Shimada T, Cheng L, Yamazaki A, et al. Effects of lysed Enterococcus faecalis FK-23 on allergen-induced serum antibody responses and active cutaneous anaphylaxis in mice. Clin Exp Allergy 2004; 34: 1784-8.
20. Shimada T, Cheng L, Enomoto T, Yang X, Miyoshi A, Shirakawa T. Lysed Enterococcus faecalis FK-23 oral administration reveals inverse association between tuberculin responses and clinical manifestations in perennial allergic rhinitis: a preliminary study. J Invest Allergol Clin Immunol 2004; 14: 187-92.
21. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria Japonica) pollen. J Allergy Clin Immunol 1983; 71: 77-86.
22. Kaneko M, Yazumichi H, Takatsu K, Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol 1991; 96: 41-5.
23. Shimada T, Zhu LP, Yin M, et al. Effects of lysed Enterococcus faecalis FK-23 on allergen-induced peritoneal accumulation of eosinophils and serum total IgE concentration in inbred mice. Asian Pac J Allergy Immunol 2008; 26: 137-41.
24. Mori H, Kurata H, Shimazaki Y, Yoshimoto T. Comparative study of Kampo preparations sho-sei-ryu-to and kei-ma-kakuhan-to for nasal allergic conjunctivitis in spring. Ther Res 1999; 20: 2941-7. (in Japanese with English abstract).
25. Yamagiwa M. Effect of sho-sei-ryu-to (xiao-qing-long-tang) on nasal obstruction in patients with perennial nasal allergy. ORL Clinic 1997; 92: 38-42. (in Japanese with English ab-stract)
26. Miyamoto T, Inoue H, Kitamura S, et al. Effect of TSU-MURA sho-seiryu-to (TJ-19) on bronchitis in a double-blind placebo-controlled study. J Clin Ther Med 2001; 17: 1189-214. (in Japanese with English abstract)
27. Nyunt AK, Takeuchi Y, Yokomuro K, Miyanaga Y. Comparative studies on the antiallergic effects of kampo medicine used for the therapy of respiratory diseases. Jpn J Allergol 1995; 44: 503-12.
28. Nagai T, Arai Y, Emori M, et al. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immnopharmacol 2004; 4: 1353-65.
29. Hata Y, Uehara H. A case where herbal medicine sho-seiryu-to induced interstitial pneumonitis. Nihon Kokyuki Gakkai Zasshi 2005; 43: 23-31 (in Japanese).
30. Zuo F, Zhou ZM, Yan MZ, et al. Metabolism of constituents in Huangqin-Tang, a prescription in traditional Chinese medicine, by human intestinal flora. Biol Pharm Bull 2002; 25: 558-63.
31. Kobashi K. Glycosides are natural products: evidence using germfree and gnotobiotic rats associated with a human intestinal bacterium. J Trad Med 1998; 15: 1-13.
32. Shimada T, Cheng L, Shi H-B, et al. Effect of lysed Enterococcus faecalis FK-23 on allergen-induced immune responses and intestinal microflora in antibiotic treated weaning mice. J Invest Allergol Clin Immunol 2007; 17: 70-6.
33. Kobashi K, Akao T, Hattori M, Namba T. Metabolism of drugs by intestinal bacteria. Bifidobacteria microflora 1992; 11: 9-23.
34. Kobashi K, Akao T. Relation of intestinal bacteria to pharmacological effects of glycosides. Bioscience Microflora 1997; 16: 1-7.
35. Wakabayashi C, Hasegawa H, Murata J, Saiki I. In vitro antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 1997; 9: 411-417.
36. Wakabayashi C, Hasegawa H, Murata J, Saiki I. The expression of in vivo anti-metastatic effect of ginseng protopanaxatriol saponins is mediated by their intestinal bacterial metabolites after oral administration. J Trad Med 1997; 14: 180-5.